Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Verantos logo — High-validity real-world evidence across all therapeutic are...

Verantos

High-validity real-world evidence across all therapeutic areas at scale

Founded 2015 United States Menlo Park, United States 57 employees Grant Total: $1.42M Health Care, Pharmaceutical

General Information

Company Name Verantos
Founded Year 2015
Location United States Menlo Park, United States
Employees 57
Industries Health Care, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Verantos. To contact Verantos, visit verantos.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Verantos compare?

A PDF of Verantos and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Verantos soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Verantos

Verantos is a leading player in the field of high-validity real-world evidence across all therapeutic areas in life sciences. The company's slogan, "High-validity real-world evidence across all therapeutic areas at scale," reflects its commitment to leveraging robust clinical narrative data and artificial intelligence technology to produce research-grade evidence at a large scale. Established in 2013 and headquartered in the United States, Verantos has received a $1.20M grant investment from the National Science Foundation on 20 December 2020. The Verantos Real-World Evidence (RWE) platform is designed to integrate diverse real-world data sources, generating evidence with the accuracy necessary for market access, medical affairs, and regulatory purposes within the Health Care and Pharmaceutical industries.

Taxonomy: Real-world evidence, Therapeutic areas, Life sciences, Clinical data, Artificial intelligence technology, Validity measurement, Research-grade evidence, RWE platform, Real-world data sources, Market access, Health economics and outcomes research (HEOR), Regulatory use, Medical affairs

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $1.20M 1
National Science Foundation
National Science Foundation
20 Dec 2020
Grant $224.79K 1
National Science Foundation
National Science Foundation
25 Jun 2018

Verantos Alternatives & Competitors

View All Alternatives
Verantos vs
Human Data Sciences
Human Data Sciences United Kingdom

Experts in real-world evidence generation. Delivering intelligence in minutes and studies in days —...

Venture round
38 employees
Biotechnology, Health Care
Verantos vs
Magnolia Market Access
Magnolia Market Access United States

Reimbursement & Patient Services | Policy Analytics | HEOR & RWE | Pricing & Distribution | Value Co...

19 employees
Biopharma, Health Care
Verantos vs
OKRA.ai
OKRA.ai United Kingdom

AI analytics for healthcare, providing real-time evidence-based insights and predictions to empower...

Seed
16 employees
AI, Analytics
View all alternatives

FAQ About Verantos

High-validity real-world evidence across all therapeutic areas at scale
Verantos was founded in 2015.
Verantos is headquartered in Menlo Park, United States.
Verantos operates in Health Care and Pharmaceutical. Its work centres on Real-world evidence, Therapeutic areas, Life sciences and Clinical data.
Verantos has approximately 57 employees.
Verantos has completed 2 funding rounds, raising a total of $1.42M. The latest funding stage is Grant.
Top alternatives and competitors to Verantos include Human Data Sciences, Magnolia Market Access, OKRA.ai, BioPoint Inc., Certara. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Verantos and Human Data Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Verantos, https://bouncewatch.com/company/verantos, updated 4 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes